On the Web...
Workshop Registrations
Companies
Categories
- ADMET (63)
- Bioinformatics (60)
- Biomarkers (38)
- Books (6)
- Chemical Databases (107)
- Chemical Information & Publishing (107)
- Cheminformatics (135)
- Combichem (50)
- Computational Biology (55)
- Current Affairs (22)
- Drug Discovery (135)
- Electronic Lab Notebooks (27)
- ELNs (16)
- Film (2)
- Food and Drink (7)
- Games (2)
- Grid Computing (20)
- Integration & Standards (79)
- Materials Science (14)
- Medicinal Chemistry (82)
- Membranes (13)
- Metabolomics (28)
- Molecular Graphics & Visualisation (81)
- Molecular Modelling (128)
- Music (1)
- Nanotechnology (24)
- Open Source (72)
- Proteins (85)
- QM (33)
- QSAR (89)
- Religion (1)
- Science (132)
- Sports (2)
- Structure-based Drug Design (78)
- Television (1)
- Toxicology (68)
- Training (25)
- Travel (5)
- Trees (2)
- Virtual Screening (99)
- Web Services (79)
- Web/Tech (61)
- Weblogs (11)
My Bloglines
« OpenTox USA 2013 speaker program | Main | OpenTox Euro 2013 Awards »
October 05, 2013
The comments to this entry are closed.
Communities of Practice
Recent Posts
- Presentations in Boston on OpenTox, eCheminfo, ToxBank, eNanoMapper
- OpenTox Association founding
- eCheminfo Drug Design Bursary Awards
- eCheminfo Drug Design Meeting, Johns Hopkins, 9 - 11 Feb 2015
- Drug Design in India, Malaria Focus
- OpenTox USA 2015 program open
- ToxBank Public Access
- eCheminfo Oxford 2014 drug design workshop event page
- eCheminfo workshop will apply computational methods to novel anti-malarial drug design
- OpenTox Euro 2014 to highlight industrial and regulatory advances
Blogs
eCheminfo Chairs, Presenters & Instructors
- Jeff Wiseman
- Jim Wikel
- Jeroen H. Nieuwenhuis
- David Mosenkis
- Victor Lobanov
- G. Scott Lett
- Gérard Hopfgartner
- Alan Gibbs
- Jim Cook
- Steve Boyer
- Lars Blank
- Ruhong Zhou
- Peter Winn
- Wolfgang Wenzel
- Michele Vendruscolo
- Wilfred van Gunsteren
- Guido Tiana
- David Teplow
- Jeremy Smith
- Joan-Emma Shea
- Jed Pitera
- Vijay Pande
- Andrew Miranker
- Thomas Kiefhaber
- Marc Fasnacht
- Yong Duan
- Nikolay Dokholyan
- Richard Dixon
- Feng Ding
- Xavier Daura
- Sergey Buldyrev
- Ning Yu
- Darrin York
- Ian Williams
- Lance Westerhoff
- Paul Tavan
- Ursula Roethlisberger
- Ramkumar Rajamani
- Kaushik Raha
- Martin Peters
- Adrian Mulholland
- Gerald Monard
- Ken Merz
- Harald Lanig
- Jiali Gao
- Richard Friesner
- Alessandro Curioni
- Richard Bryce
- Miklos Vargyas
- Didier Rognan
- Graham Richards
- Emanuele Perola
- Willem Nissink
- David Morley
- Mark McGann
- John Irwin
- Renee DesJarlais
- Max Cummings
- Amedeo Caflisch
- Xavier Barril
- Brett Tounge
- Torsten Schwede
- Dmitrii Rassokhin
- Vladimir Poroikov
- Marc Nicklaus
- Eugene Krissinel
- Alexander Kel
- John Irwin
- Kim Henrick
- Adel Golovin
- Johann Gasteiger
- Brad Feuston
- Dimitris Dimitropoulos
- Joao Aires de Sousa
- David Covell
- Simon Coles
- Steve Bryant
- Andreas Bender
- Stan Young
- John van Drie
- Rajeshri Karki
- Val Gillet
- Peter Willett
- Jörg Kurt Wegner
- Gisbert Schneider
- Stefan Kramer
- Joost N. Kok
- Christoph Helma
- Michael Berthold
- Jens Walther
- Nick Quirke
- Richard Gilbert
- Joachim Franzke
- Andrew deMello
- Tom Woolf
- Emad Tajkhorshid
- Anna Skibinsky
- Andrew Pohorill
- Mike Pitman
- Richard Pastor
- Preston Moore
- Jeff Klauda
- Gerhard Hummer
- Scott Feller
- Indira Chandrasekhar
- Max Berkowitz
- Rob Brown
- Mark Cronin
- Scott McDonald
- Lennart Eriksson
- David Lloyd
- Jas Gata-Aura
- Paul Hawkins
- David Gallagher
- Daniel Butler
- Gyorgy Pirok
Recent Comments
- Barry Hardy on Goodbye Patrik, we will miss you.
- crystal on Trees talk to each other to create toxic defences
- Ryan Mercer on Trees talk to each other to create toxic defences
- כסאות מנהלים סופרדסק on Structure-based Drug Design
- bike clothes on OpenTox 2011 Poster Session in Predictive Toxicology
- chemistry Link centre on AXLR8 2010 report on Alternative Testing Strategies
- g on Our approach to drug design
- Mayuri on Applications of Cheminformatics and Chemical Modelling to Drug Discovery
- S D WARKAD on Structure-based Drug Design
- Rich Apodaca on Blending meeting presentations with virtual community activity
Comments